September quarter and half-year results published, with no dividend recommended

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.9%Reaction day

₹7.30

prior close

₹7.66

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.7%+3.2% vs market

Pharmaceuticals peers, median of 173sector+2.0%+3.0% vs sector

On the reaction day the stock moved 3.2 pts more than Nifty Microcap 250 and 3.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.9+1.7+3.2+2.0+3.0

Next day

+10.1+1.8+8.3+2.6+7.5

+9.6pendingpending+2.6+6.9

———+1.9—

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Achyut Healthcare filed newspaper clippings dated 27 October 2026 showing publication of its unaudited results for the quarter and half-year ended 30 September 2026 in Jai Hind and Business Standard under SEBI LODR Regulation 47. The board approved the results on 15 October 2026 and recommended no dividend for either period.

Likely market impact

Compliance filing with no new figures. The recommended no dividend offers no income support, so the direct stock impact is likely neutral.